li, Xiaofeng
Chen, Yiwen
Wang, Ting
Liu, Zifan
Yin, Guotao
Wang, Ziyang
Sui, Chunxiao
Zhu, Lei
Chen, Wei
Funding for this research was provided by:
National Natural Science Foundation of China (82272074, 81601377, 81801781)
Article History
Received: 16 February 2023
Accepted: 31 May 2023
First Online: 27 July 2023
Declarations
:
: The study was approved by the Ethics Review Committee of Tianjin Medical University Cancer Institute and Hospital and conducted in strict accordance with the Declaration of Helsinki in 1964 and its later amendments. Additionally, the collection and use of human peripheral blood samples were approved by the Ethic Review Committee of Tianjin Blood Center, and written informed consent was waived in the study. Regarding animal experiments, all procedures performed in the study were in compliance with ational Institutes of Health Guide for the Care and Use of Laboratory Animals, and the research protocol was approved by the Animal Ethics Review Committee of Tianjin Medical University Cancer Institute and Hospital. Accordingly, the maximal tumor size/burden of 1cm<sup>3</sup> was not exceeded in the animal experiments.
: Written informed consent to collect and analyze the human BC tissues and human blood samples was waived by the Ethics Review Committee of Tianjin Medical University Cancer Institute and Hospital in this retrospective study. Additionally, all authors agree to publish this article.
: The authors declare that there are no competing interests in this study.